BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34729087)

  • 1. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 7:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06859. PubMed ID: 34729087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 13:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06865. PubMed ID: 34729093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 9:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06861. PubMed ID: 34729089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 5:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06856. PubMed ID: 34729085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 8:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06860. PubMed ID: 34729088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 4:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06855. PubMed ID: 34729084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 11:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06863. PubMed ID: 34729091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 6:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06858. PubMed ID: 34729086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 10:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06862. PubMed ID: 34729090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 12:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06864. PubMed ID: 34729092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2:
    ; Allende A; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06853. PubMed ID: 34729082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 3:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06854. PubMed ID: 34729083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1:
    ; Koutsoumanis K; Allende A; Alvarez-Ordóñez A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Ru G; Simmons M; Skandamis P; Suffredini E; Andersson DI; Bampidis V; Bengtsson-Palme J; Bouchard D; Ferran A; Kouba M; López Puente S; López-Alonso M; Nielsen SS; Pechová A; Petkova M; Girault S; Broglia A; Guerra B; Innocenti ML; Liébana E; López-Gálvez G; Manini P; Stella P; Peixe L
    EFSA J; 2021 Oct; 19(10):e06852. PubMed ID: 34729081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches for the simultaneous detection of thiamphenicol, florfenicol and florfenicol amine using immunochemical techniques.
    Fodey TL; George SE; Traynor IM; Delahaut P; Kennedy DG; Elliott CT; Crooks SR
    J Immunol Methods; 2013 Jul; 393(1-2):30-7. PubMed ID: 23587555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical note: Development of an enzyme-linked immunosorbent assay for the determination of florfenicol and thiamphenicol in swine feed.
    Luo PJ; Jiang WX; Chen X; Shen JZ; Wu YN
    J Anim Sci; 2011 Nov; 89(11):3612-6. PubMed ID: 21724944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between two amphenicol of antibiotics, florfenicol and thiamphenicol, against Staphylococcus aureus.
    Wei CF; Chang SK; Shien JH; Kuo HC; Chen WY; Chou CC
    Vet Rec; 2016 Mar; 178(13):319. PubMed ID: 26864028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of LC-MS/MS methodology for the detection/determination and confirmation of chloramphenicol, chloramphenicol 3-O-β-d-glucuronide, florfenicol, florfenicol amine and thiamphenicol residues in bovine, equine and porcine liver.
    Fedeniuk RW; Mizuno M; Neiser C; O'Byrne C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():68-78. PubMed ID: 25913426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs.
    Ueda Y; Ohtsuki S; Narukawa N
    J Vet Med Sci; 1995 Apr; 57(2):261-5. PubMed ID: 7492643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the leaching of florfenicol from coated medicated fish feed into water.
    Barreto FM; da Silva MR; Braga PAC; Bragotto APA; Hisano H; Reyes FGR
    Environ Pollut; 2018 Nov; 242(Pt B):1245-1252. PubMed ID: 30118912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.